Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2001 1
2002 1
2005 1
2007 3
2008 2
2009 1
2010 2
2011 1
2015 1
2016 1
2017 1
2018 6
2019 7
2020 6
2021 8
2022 8
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Antibody-Drug Conjugates: The Last Decade.
Joubert N, Beck A, Dumontet C, Denevault-Sabourin C. Joubert N, et al. Pharmaceuticals (Basel). 2020 Sep 14;13(9):245. doi: 10.3390/ph13090245. Pharmaceuticals (Basel). 2020. PMID: 32937862 Free PMC article. Review.
Therapeutic antibodies - natural and pathological barriers and strategies to overcome them.
Al Ojaimi Y, Blin T, Lamamy J, Gracia M, Pitiot A, Denevault-Sabourin C, Joubert N, Pouget JP, Gouilleux-Gruart V, Heuzé-Vourc'h N, Lanznaster D, Poty S, Sécher T. Al Ojaimi Y, et al. Among authors: joubert n. Pharmacol Ther. 2022 May;233:108022. doi: 10.1016/j.pharmthera.2021.108022. Epub 2021 Oct 20. Pharmacol Ther. 2022. PMID: 34687769 Free PMC article. Review.
Protein chemical modification on endogenous amino acids.
Baslé E, Joubert N, Pucheault M. Baslé E, et al. Among authors: joubert n. Chem Biol. 2010 Mar 26;17(3):213-27. doi: 10.1016/j.chembiol.2010.02.008. Chem Biol. 2010. PMID: 20338513 Review.
Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in resistant metastatic colorectal cancer cells.
Cherradi S, Garambois V, Marines J, Andrade AF, Fauvre A, Morand O, Fargal M, Mancouri F, Ayrolles-Torro A, Vezzo-Vié N, Jarlier M, Loussaint G, Huvelle S, Joubert N, Mazard T, Gongora C, Pourquier P, Boissière-Michot F, Rio MD. Cherradi S, et al. Among authors: joubert n. Cell Biosci. 2023 Apr 11;13(1):72. doi: 10.1186/s13578-023-01015-5. Cell Biosci. 2023. PMID: 37041570 Free PMC article.
Automated treatment planning of postmastectomy radiotherapy.
Kisling K, Zhang L, Shaitelman SF, Anderson D, Thebe T, Yang J, Balter PA, Howell RM, Jhingran A, Schmeler K, Simonds H, du Toit M, Trauernicht C, Burger H, Botha K, Joubert N, Beadle BM, Court L. Kisling K, et al. Among authors: joubert n. Med Phys. 2019 Sep;46(9):3767-3775. doi: 10.1002/mp.13586. Epub 2019 Jul 9. Med Phys. 2019. PMID: 31077593 Free PMC article.
Branched pegylated linker-auristatin to control hydrophobicity for the production of homogeneous minibody-drug conjugate against HER2-positive breast cancer.
Douez E, Allard-Vannier E, Amar IAM, Jolivet L, Boursin F, Maisonial-Besset A, Witkowski T, Chezal JM, Colas C, Letast S, Auvert E, Denevault-Sabourin C, Aubrey N, Joubert N. Douez E, et al. Among authors: joubert n. J Control Release. 2024 Feb;366:567-584. doi: 10.1016/j.jconrel.2024.01.012. Epub 2024 Jan 13. J Control Release. 2024. PMID: 38215985
54 results